Sarah A. Pendergrass

Sarah A. Pendergrass

Auto-generated profile, based on publicly available information

Sarah A. Pendergrass

Center for Systems Genomics, Pennsylvania State University, University Park, PA 16802, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
JDJoshua C Denny
Joshua C Denny
LBLisa Bastarache
Lisa Bastarache
MRMarylyn D Ritchie
Marylyn D Ritchie
RCRobert J Carroll
Robert J Carroll
RZRaquel Zink
Raquel Zink
DRDan M Roden
Dan M Roden

13 January 2015 in Nature Reviews Genetics
Verified
Journal Article
Closed access
MRMarylyn D. Ritchie
Marylyn D. Ritchie
EHEmily R. Holzinger
Emily R. Holzinger
RLRuowang Li
Ruowang Li
SPSarah A. Pendergrass
Sarah A. Pendergrass
DKDokyoon Kim
Dokyoon Kim

23 December 2016 in Science
Verified
Journal Article
Closed access
PDF file
FDFrederick E. Dewey
Frederick E. Dewey
MMMichael F. Murray
Michael F. Murray
JOJohn D. Overton
John D. Overton
LHLukas Habegger
Lukas Habegger
JLJoseph B. Leader
Joseph B. Leader
DCDavid J. Carey
David J. Carey
Unleashing the power of precision medicine: Precision medicine promises the ability to identify risks and treat patients on the basis of pathogenic genetic variation. Two studies combined exome sequencing results for over 50,000 people with their electronic health records. Dewey et al. found that ∼3.5% of individuals in their cohort had clinically actionable genetic variants. Many of these variants affected blood lipid levels that could influence cardiovascular health. Abul-Husn et al. extended these findings to investigate the genetics and treatment of familial hypercholesterolemia, a risk factor for cardiovascular disease, within their patient pool. Genetic screening helped identify at-risk patients who could benefit from increased treatment. Science , this issue p. 10.1126/science.aaf6814 , p. 10.1126/science.aaf7000

16 July 2008 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMAusra Milano
Ausra Milano
SPSarah A. Pendergrass
Sarah A. Pendergrass
JSJennifer L. Sargent
Jennifer L. Sargent
LGLacy K. George
Lacy K. George
TMTimothy H. McCalmont
Timothy H. McCalmont
MWMichael L. Whitfield
Michael L. Whitfield
Scleroderma is a clinically heterogeneous disease with a complex phenotype. The disease is characterized by vascular dysfunction, tissue fibrosis, internal organ dysfunction, and immune dysfunction resulting in autoantibody production. We analyzed the genome-wide patterns of gene expression with DNA microarrays in skin biopsies from distinct scleroderma subsets including 17 patients with systemic sclerosis (SSc) with diffuse scleroderma (dSSc), 7 patients with SSc with limited scleroderma (lSSc), 3 patients with morphea, and 6 healthy controls. 61 skin biopsies were analyzed in a total of 75 microarray hybridizations. Analysis by hierarchical clustering demonstrates nearly identical patterns of gene expression in 17 out of 22 of the forearm and back skin pairs of SSc patients. Using this property of the gene expression, we selected a set of ‘intrinsic’ genes and analyzed the inherent data-driven groupings. Distinct patterns of gene expression separate patients with dSSc from those with lSSc and both are easily distinguished from normal controls. Our data show three distinct patient groups among the patients with dSSc and two groups among patients with lSSc. Each group can be distinguished by unique gene expression signatures indicative of proliferating cells, immune infiltrates and a fibrotic program. The intrinsic groups are statistically significant (p<0.001) and each has been mapped to clinical covariates of modified Rodnan skin score, interstitial lung disease, gastrointestinal involvement, digital ulcers, Raynaud's phenomenon and disease duration. We report a 177-gene signature that is associated with severity of skin disease in dSSc. Genome-wide gene expression profiling of skin biopsies demonstrates that the heterogeneity in scleroderma can be measured quantitatively with DNA microarrays. The diversity in gene expression demonstrates multiple distinct gene expression programs in the skin of patients with scleroderma.

11 September 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
ATAlexander Teumer
Alexander Teumer
YLYong Li
Yong Li
SGSahar Ghasemi
Sahar Ghasemi
BPBram Peter Prins
Bram Peter Prins
MWMatthias Wuttke
Matthias Wuttke
AKAnna Köttgen
Anna Köttgen
Increased levels of the urinary albumin-to-creatinine ratio (UACR) are associated with higher risk of kidney disease progression and cardiovascular events, but underlying mechanisms are incompletely understood. Here, we conduct trans-ethnic (n = 564,257) and European-ancestry specific meta-analyses of genome-wide association studies of UACR, including ancestry- and diabetes-specific analyses, and identify 68 UACR-associated loci. Genetic correlation analyses and risk score associations in an independent electronic medical records database (n = 192,868) reveal connections with proteinuria, hyperlipidemia, gout, and hypertension. Fine-mapping and trans-Omics analyses with gene expression in 47 tissues and plasma protein levels implicate genes potentially operating through differential expression in kidney (including TGFB1, MUC1, PRKCI, and OAF), and allow coupling of UACR associations to altered plasma OAF concentrations. Knockdown of OAF and PRKCI orthologs in Drosophila nephrocytes reduces albumin endocytosis. Silencing fly PRKCI further impairs slit diaphragm formation. These results generate a priority list of genes and pathways for translational research to reduce albuminuria.

16 October 2013 in BioData Mining
Verified
Journal Article
Open access
PDF file
DWDaniel Wolfe
Daniel Wolfe
SDScott Dudek
Scott Dudek
MRMarylyn Ritchie
Marylyn Ritchie
SPSarah A Pendergrass
Sarah A Pendergrass
Background: With the abundance of information and analysis results being collected for genetic loci, user-friendly and flexible data visualization approaches can inform and improve the analysis and dissemination of these data. A chromosomal ideogram is an idealized graphic representation of chromosomes. Ideograms can be combined with overlaid points, lines, and/or shapes, to provide summary information from studies of various kinds, such as genome-wide association studies or phenome-wide association studies, coupled with genomic location information. To facilitate visualizing varied data in multiple ways using ideograms, we have developed a flexible software tool called PhenoGram which exists as a web-based tool and also a command-line program. Results: With PhenoGram researchers can create chomosomal ideograms annotated with lines in color at specific base-pair locations, or colored base-pair to base-pair regions, with or without other annotation. PhenoGram allows for annotation of chromosomal locations and/or regions with shapes in different colors, gene identifiers, or other text. PhenoGram also allows for creation of plots showing expanded chromosomal locations, providing a way to show results for specific chromosomal regions in greater detail. We have now used PhenoGram to produce a variety of different plots, and provide these as examples herein. These plots include visualization of the genomic coverage of SNPs from a genotyping array, highlighting the chromosomal coverage of imputed SNPs, copy-number variation region coverage, as well as plots similar to the NHGRI GWA Catalog of genome-wide association results. Conclusions: PhenoGram is a versatile, user-friendly software tool fostering the exploration and sharing of genomic information. Through visualization of data, researchers can both explore and share complex results, facilitating a greater understanding of these data.